CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The STROGHAT project aims to evaluate a new 'Screen & treat' strategy using acoziborole, a non-toxic oral medication, to effectively reduce the prevalence of Gambiense human African trypanosomiasis in the Democratic Republic of Congo. This approach simplifies diagnosis and treatment, potentially improving access and ou…
Gambiense human African trypanosomiasis (gHAT) is a neglected tropical disease caused by trypanosome parasites. gHAT is fatal if left untreated.
So far, treatment options for gHAT were limited and toxic, forcing control programs to avoid overtreatment through complex diagnostic procedures, including screening with a serological test, laborious microscopic confirmation of seropositives and lumbar puncture for disease stage determination.
This resulted in loss of up to 50% of gHAT cases, which rem…
INSTITUUT VOOR TROPISCHE GENEESKUNDE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
PROGRAMME NATIONAL DE LUTTE CONTRE LA TRYPANOSOMIASE HUMAINE
Congo - Kinshasa, KINSHASA
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Congo - Kinshasa, KINSHASA GOMBE
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
